Theranostics of targeted PSMA: application and progress

ZHANG Zhaoqi; ZHAO Xinming

doi:10.19732/j.cnki.2096-6210.2024.05.003

您当前的位置：

首页 >

文章列表页 >

Theranostics of targeted PSMA: application and progress

更新时间：2025-12-15

- Theranostics of targeted PSMA: application and progress
- Vol. 33, Issue 5, Pages: 475-484(2024)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.19732/j.cnki.2096-6210.2024.05.003
  CLC：
- Published Online：07 November 2024，
  
  Published：07 November 2024
- 稿件说明：
移动端阅览
张召奇,赵新明. 靶向PSMA诊疗一体化：应用与进展[J]. 肿瘤影像学, 2024, 33(5): 475-484 https://doi.

org/10.19732/j.cnki.2096-6210.2024.05.003
张召奇,赵新明. 靶向PSMA诊疗一体化：应用与进展[J]. 肿瘤影像学, 2024, 33(5): 475-484 https://doi. DOI： 10.19732/j.cnki.2096-6210.2024.05.003.

org/10.19732/j.cnki.2096-6210.2024.05.003 DOI：

摘要

前列腺特异性膜抗原（prostate-specific membrane antigen，PSMA）最早在前列腺癌细胞中发现，是前列腺癌等高表达PSMA肿瘤诊疗的重要靶点。多种显像和治疗核素标记的PSMA不同配体在前列腺癌诊疗一体化中显示出重要作用。本文就靶向PSMA诊疗一体化的相关研究和临床应用进展进行述评。

Abstract

Prostate specific membrane antigen (PSMA) was first discovered in prostate cancer cells and is an important target for the diagnosis and treatment of tumors with high expression of PSMA such as prostate cancer. The development and application of a variety of imaging and therapeutic radionuclide-labeled targeted PSMA ligands play an important role in the theranostics of prostate cancer. This article reviewed the relevant research and clinical applications theranostics of PSMA.

关键词

Keywords

references

Views

356

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

A comparative study of ⁶⁸Ga-TBM-001 PET/CT and ^99mTc-MDP bone scintigraphy in the diagnosis of bone metastases of prostate cancer

Initial clinical study of a novel prostate cancer imaging agent, ⁶⁸ Ga-PSMA-4PY

Application and progress of PSMA probes in the diagnosis and treatment of prostate cancer

Clinical value of ^99mTc-PSMA SPECT/CT in detection of prostate cancer

Advances in radioimmunotherapy targeting prostate specific membrane antigen in prostate cancer

Related Author

Dan SU

Taoming DU

Yue CHEN

ZHANG Xiaojun

LIU Huanhuan

LIU Yachao

WANG Ruimin

ZHANG Jinming

Related Institution

Department of Nuclear Medicine, Affilitated Hospital of Southwest Medical University

Department of Nuclear Medicine, Chengdu Seventh People’s Hospital, Affilitated Cancer Hospital of Chengdu Medical College

Department of Radiology, Chengdu Seventh People’s Hospital, Affilitated Cancer Hospital of Chengdu Medical College

Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University Cancer Research Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine

Department of Nuclear Medicine, Henan Cancer Hospital

AI问答

⁰